Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsAlex Ganetsky, David Porter, Jennifer Han et al.|Clinical Infectious Diseases|2018Cited by 79
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, David Porter, Noelle V. Frey et al.|Bone Marrow Transplantation|2018Cited by 48
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical TrialRan Reshef, David Porter, Robin Blauser et al.|Transplantation and Cellular Therapy|2018Cited by 31
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W. Freyer, Selina M. Luger, Alison Carulli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 10
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamideCraig W. Freyer, Alison W. Loren, Alison Carulli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 10